Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Z Ferl

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Magnetic Resonance in Medicine|May 1, 2010
An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumabGregory Z Ferl, Lu Xu, Michel Friesenhahn, et al.
Clinical and Translational Science|January 20, 2018
A Preclinical Population Pharmacokinetic Model for Anti-CD20/CD3 T-Cell-Dependent Bispecific AntibodiesGregory Z Ferl, Arthur Reyes, Liping L Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytesDavid A Fruman, Gregory Z Ferl, Sam S An, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2004
A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activationShuling Guo, Gregory Z Ferl, Rajendar Deora, et al.
Mabs|July 22, 2022
Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodiesHanine Rafidi, Sharmila Rajan, Konnie Urban, et al.
Plos One|March 26, 2011
Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flowC Andrew Boswell, Gregory Z Ferl, Eduardo E Mundo, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 21, 2026
Tracer kinetic modeling of a 14 kDa anti-CD8 PET tracer (2C8v144) for in vivo estimation of CD8 expression in tissue and blood, binding affinity, and total body receptor occupancyRuediger E Port, C Andrew Boswell, Annie Ogasawara, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 23, 2014
Mixed-effects modeling of clinical DCE-MRI data: application to colorectal liver metastases treated with bevacizumabGregory Z Ferl, James P B O'Connor, Geoffrey J M Parker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing miceGregory Z Ferl, Rebecca A Dumont, Isabel J Hildebrandt, et al.
Molecular Pharmaceutics|February 19, 2026
Evaluation of RBC Targeting As a Strategy to Extend Half-Life and Reduce Nonspecific Tissue Uptake of BiologicsNicholas Cho, Hanine Rafidi, Travis Morgenstern, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Magnetic Resonance in Medicine|May 1, 2010
An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumabGregory Z Ferl, Lu Xu, Michel Friesenhahn, et al.
Clinical and Translational Science|January 20, 2018
A Preclinical Population Pharmacokinetic Model for Anti-CD20/CD3 T-Cell-Dependent Bispecific AntibodiesGregory Z Ferl, Arthur Reyes, Liping L Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytesDavid A Fruman, Gregory Z Ferl, Sam S An, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2004
A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activationShuling Guo, Gregory Z Ferl, Rajendar Deora, et al.
Mabs|July 22, 2022
Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodiesHanine Rafidi, Sharmila Rajan, Konnie Urban, et al.
Plos One|March 26, 2011
Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flowC Andrew Boswell, Gregory Z Ferl, Eduardo E Mundo, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 21, 2026
Tracer kinetic modeling of a 14 kDa anti-CD8 PET tracer (2C8v144) for in vivo estimation of CD8 expression in tissue and blood, binding affinity, and total body receptor occupancyRuediger E Port, C Andrew Boswell, Annie Ogasawara, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 23, 2014
Mixed-effects modeling of clinical DCE-MRI data: application to colorectal liver metastases treated with bevacizumabGregory Z Ferl, James P B O'Connor, Geoffrey J M Parker, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing miceGregory Z Ferl, Rebecca A Dumont, Isabel J Hildebrandt, et al.
Molecular Pharmaceutics|February 19, 2026
Evaluation of RBC Targeting As a Strategy to Extend Half-Life and Reduce Nonspecific Tissue Uptake of BiologicsNicholas Cho, Hanine Rafidi, Travis Morgenstern, et al.
Pageof 4